The company uses brain computer interface (BCI) technology to offer bespoke neural assessment and therapy for mental health conditions.

These patents are valid till 2036 and 2033 respectively, the company said in a BSE filing.

Suven Life said it has been granted "one product patent from New Zealand corresponding to the NCEs for the treatment of disorders associate...

The molecules are being developed for the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's d...

Suven Life said it has been granted "one product patent from the US corresponding to the new chemical entities (NCEs) for the treatment of ...

The company was granted patents from Europe and Israel corresponding to the NCEs for the treatment of disorders associated with neuro-degen...

In a BSE filing today, it said it has been granted "one product patent from Europe and two patents from Eurasia corresponding to New Chemic...

With these new patents, Suven has a total of 24 granted patents from Australia, 17 from Eurasia and 9 from Israel and 24 from the US.

Shares of Suven Life Sciences ended with nearly 2 per cent gains today as the company won patent for a drug, used in treatment of neuro-deg...

The company has been granted "one product patent from China, one product patent from Eurasia and one product patent from Hong Kong correspo...

Suven Life Sciences has been granted a patent each by China, Eurasia and Hong Kong for a drug used in the treatment of neuro-degenerative d...

With these new patents, Suven has a total of 23 granted patents from Australia and 22 from Canada.

These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts.

The firm has been granted patents each by Canada, Japan and Korea for molecules, aimed to be developed as drugs, for the treatment of neuro...

Neuro-degenerative ailments include Alzheimer's disease, Schizophrenia and Parkinson's disease.

Suven Life Sciences Ltd gets four product patents one each from Australia, Canada, Korea and New Zealand for their new drug molecules (New ...

Suven Life Sciences has received product patents in India for three new chemical entities 208688, 208714 and 209540 for treatment of disord...